Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutations.
Adult
Age of Onset
Biomarkers, Tumor
/ genetics
Breast Neoplasms
/ genetics
Class I Phosphatidylinositol 3-Kinases
/ genetics
DNA Mutational Analysis
Female
Genetic Predisposition to Disease
Heredity
High-Throughput Nucleotide Sequencing
Humans
Middle Aged
Mutation
Papilloma
/ genetics
Pedigree
Phenotype
Proto-Oncogene Proteins c-akt
/ genetics
Breast cancer
Genetic link
Juvenile papillomatosis
Mutations
Positive family history
Journal
Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
27
08
2019
revised:
02
02
2020
accepted:
16
02
2020
pubmed:
24
2
2020
medline:
27
10
2020
entrez:
24
2
2020
Statut:
ppublish
Résumé
Juvenile papillomatosis (JP), the so-called Swiss cheese disease, is a rare benign breast disease of young adults. An association (up to 28%) with breast cancer within the family of affected patients has been reported. A multinodular cystic breast mass lesion and calcifications characterizes JP in imaging studies. The histological picture is diverse and comprises multiple intraductal papillomas, usual ductal hyperplasia, ductectasias, perifocal sclerosing adenosis, and calcification. Patients with complete excision of JP lesions have an excellent follow-up; breast cancer develops only on a very low subset of patients. Molecular background of JP has not been investigated until now. In this study, we addressed mutational analysis of JP cases and correlated these results with follow-up and family history in context with a comprehensive review of the JP literature. We identified 13 cases fulfilling the criteria of JP. All patients were women with a median age of 38 years (26-50 years). Follow-up information was available for 11 of 13 patients. Sufficient paraffin-embedded tissue and good DNA quality for next-generation sequencing (NGS) was available for 10 patients. Paraffin blocks were microdissected in the area of intraductal proliferative disease; the tissue cores underwent NGS analysis using the Oncomine Comprehensive Panel. In 5 of 10 patients, we found PIK3CA mutations; in 2 of 10 patients, we found AKT1 mutations in known hot spot regions. Further mutations in MET, FGFR3, PTEN, ATM, NF1, and GNAS genes were detected in individual patients. Some of these mutations were present at high allele frequencies suggesting germ line mutations. Two of 3 patients with positive family history had PIK3CA mutation; one patient with positive family history had an AKT1 mutation. One patient who subsequently developed invasive ductal carcinoma in the contralateral breast possibly had a germ line ATM mutation. Our results confirm hot spot mutations in PIK3CA and AKT1 genes in JP associated with positive family history for breast cancer, although these mutations are not specific for JP. The genetic link between JP, positive family history, and subsequent risk of breast cancer needs to be analyzed in further studies.
Identifiants
pubmed: 32088208
pii: S0046-8177(20)30020-4
doi: 10.1016/j.humpath.2020.02.002
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Class I Phosphatidylinositol 3-Kinases
EC 2.7.1.137
PIK3CA protein, human
EC 2.7.1.137
AKT1 protein, human
EC 2.7.11.1
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
64-73Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.